Lim, Seng Gee

Publishing since 2000 (Senior)

Has published 108 publications in 11 years

Number of publications published per year by Lim, Seng Gee. (Source : PubMed)

Distribution of publications types for Lim, Seng Gee. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Lu GD, Leung CH, Yan B, Tan CM, Low SY, Aung MO, Salto-Tellez M, Lim SG, Hooi SC. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.  Gastroenterology  2010  
•  Tan AT, Koh S, Goh W, Zhe HY, Gehring AJ, Lim SG, Bertoletti A. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B.  J. Hepatol.  2010;52;3  
•  Ahn SH, Chan HL, Chen PJ, Cheng J, Goenka MK, Hou J, Lim SG, Omata M, Piratvisuth T, Xie Q, Yim HJ, Yuen MF. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.  Hepatology international  2010;4;1  
•  Lee MH, Lim SG, Jeon SJ, Kang CJ, Cho YJ, Kim SS, Lee D, Cheong JY, Cho SW. [Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients]  The Korean journal of hepatology  2009;15;4  
•  Tan HT, Low J, Lim SG, Chung MC. Serum autoantibodies as biomarkers for early cancer detection.  FEBS J.  2009;276;23  
•  Lim LG, Lee YM, Tan L, Chang S, Lim SG. Percutaneous paraumbilical embolization as an unconventional and successful treatment for bleeding jejunal varices.  World J. Gastroenterol.  2009;15;30  
•  Lim SG, Mohammed R, Yuen MF, Kao JH. Prevention of hepatocellular carcinoma in hepatitis B virus infection.  J. Gastroenterol. Hepatol.  2009;24;8  
•  Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee KH, Tan KC, Lim SG, Bertoletti A. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.  Gastroenterology  2009;137;2  
•  Zeuzem S, Gane E, Liaw YF, Lim SG, DiBisceglie A, Buti M, Chutaputti A, Rasenack J, Hou J, O'Brien C, Nguyen TT, Jia J, Poynard T, Belanger B, Bao W, Naoumov NV. Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.  J. Hepatol.  2009;51;1  
•  Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, Tan TM. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.  Cancer Sci.  2009;100;7  

[ See timeline ] [ See all publications ]